Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Akamai Technologies Receives Diverse Analyst Ratings with Varying Price Targets

Elaine Mendonca by Elaine Mendonca
January 19, 2024
in Breaking News
0
COST stock news
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

As of January 19, 2024, Akamai Technologies (NASDAQ: AKAM) has received ratings from 7 analysts, each offering their unique perspective on the company’s performance. These ratings vary from bullish to bearish, providing a comprehensive view of the stock.

The average price target for Akamai Technologies over the next 12 months is $121.29, indicating a potential increase of 13.36% from the previous average price target of $107.00. The high estimate stands at $150.00, while the low estimate is $78.00. This range showcases the diverse opinions among analysts.

Recent analyst actions have included upgrades, downgrades, and adjustments to price targets. Brandon Nispel of Keybanc upgraded the rating to “Overweight,” setting a current price target of $138.00, up from $134.00. Aaron Samuels of Susquehanna expressed a “Positive” rating with a price target of $150.00. Keith Weiss of Morgan Stanley raised the rating to “Equal-Weight,” with a price target of $112.00, up from $102.00. Rishi Jaluria of RBC Capital upgraded the rating to “Sector Perform,” setting a price target of $115.00, up from $97.00. Mark Murphy of JP Morgan downgraded the rating to “Underweight,” with a price target of $78.00, up from $74.00. Lastly, Frank Louthan of Raymond James upgraded the rating to “Outperform,” with a price target of $122.00, up from $115.00.

The latest analyst ratings reveal that there are 8 “Buy” ratings, 12 “Hold” ratings, and 2 “Sell” ratings. This consensus rating results in a classification of “Moderate Buy,” based on 4 buy ratings, 6 hold ratings, and 1 sell rating.

Considering these analyst ratings, the average 12-month price target for Akamai Technologies is $120.10. The range of estimates spans from a high of $150.00 to a low of $78.00, showcasing the disparity in opinions among analysts.

AKAM Stock Shows Strong Momentum and Positive Performance on January 19, 2024

On January 19, 2024, AKAM stock showed promising performances, according to data sourced from CNN Money. The stock was trading near the top of its 52-week range, indicating strong momentum in its price movement. Additionally, it was trading above its 200-day simple moving average, which further supports the positive sentiment surrounding the stock.

One notable aspect of AKAM’s performance on this day was the price change. The shares of AKAM had increased by $0.72 since the market last closed, representing a rise of 0.60%. This indicates that investors were optimistic about the stock and were willing to pay a higher price for it.

Furthermore, AKAM opened at $119.49, which was $0.17 higher than its previous close. This opening price suggests that there was significant demand for the stock at the start of the trading day.

Overall, AKAM stock displayed positive momentum on January 19, 2024. Its trading near the top of its 52-week range and above its 200-day simple moving average indicates that the stock has been performing well in recent times. Additionally, the price change and higher opening price further indicate investor confidence in AKAM. As always, investors should conduct thorough research and analysis before making any investment decisions.

AKAM Stock Shows Promising Growth in Revenue, Net Income, and EPS: January 19, 2024 Performance Analysis

AKAM stock performances on January 19, 2024, have shown promising growth based on the financial data provided. The data reveals positive trends in total revenue, net income, and earnings per share (EPS) for AKAM.

Starting with total revenue, AKAM recorded $3.62 billion in the past year, representing a 4.49% increase compared to the previous year. In the third quarter, the company generated $965.48 million in total revenue, indicating a 3.18% increase since the previous quarter.

Moving on to net income, AKAM reported a net income of $523.67 million in the past year. However, in the third quarter, the net income decreased by 19.64% compared to the previous year, amounting to $160.54 million. Despite the yearly decline, the net income experienced a significant 24.63% increase since the previous quarter.

Examining the earnings per share (EPS), AKAM reported an EPS of $3.26 in the past year. However, in the third quarter, the EPS decreased by 16.97% compared to the previous year, reaching $1.04. Nevertheless, the company experienced a notable 23.41% increase in EPS since the previous quarter.

Considering the overall performance of AKAM stock on January 19, 2024, investors can be optimistic. The company has demonstrated consistent growth in total revenue, despite a slight decrease in net income and EPS on a yearly basis. However, the quarterly figures show a rebound in net income and EPS, indicating that AKAM has made positive strides in its financial performance.

Investors should conduct comprehensive research and analysis before making any investment decisions.

Tags: AKAM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ stocks to buy

JPMorgan Chase A Lucrative Investment Option with Impressive Returns

Finance_Business (2)

Analyst Ratings and Price Targets for Truist Financial A Moderate Level of Optimism

Preformed Line Products Announces Dividend Payout

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com